FDA: Don't leave childhood depression untreated | Centers for Medicare and Medicaid Services |
---|---|
: Eli Lilly and Company; 2017 | Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: A systematic review and meta-analysis |
Suicidality in children and adolescents being treated with antidepressant medications.
5Centers for Medicare and Medicaid Services | Antidepressants and suicide attempts in children |
---|---|
Guidelines for adolescent depression in primary care GLAD-PC : Part 1 | Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents |
Efficacy and tolerability of antidepressants in pediatric anxiety disorders: A systematic review and meta-analysis.
22